Market Overview The global benzodiazepine drugs market  is poised for steady growth over the next decade, driven by a rising incidence of anxiety disorders, insomnia, seizures, and muscle spasms worldwide. Valued at USD 3,037.42 million in 2023, the market is projected to reach USD 4,201.27 million by 2032, expanding at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2032....